Boston Scientific Buys EndoChoice, Mulls De-FUSEing Potential Weakness

27 Sep 2016

• By Tina Tan

Boston Scientific is making a significant investment in its endoscopy portfolio as it strikes a $210m deal to buy colonoscopy specialist EndoChoice. The Natick, Massachusetts, group added that it will be “evaluating strategic options” for EndoChoice’s Fuse colonoscope.

3d render illustration of human digestive system - front view — • Source: shutterstock.com

Boston Scientific Buys EndoChoice, Mulls De-FUSEing Potential Weakness

More from Gastroenterology

More from Device Area